within Pharmacolibrary.Drugs.ATC.S;

model S02AA17
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.37,
    Cl             = 6.06 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 3000 / 1000000,
    adminCount     = 1,
    Vd             = 0.016300000000000002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005833333333333333,
    Tlag           = 19.8
  );

  annotation(Documentation(
    info ="<html><body><p>Fosfomycin is a broad-spectrum antibiotic, primarily active against Gram-negative and some Gram-positive bacteria. It is commonly used for the treatment of uncomplicated urinary tract infections, especially due to its oral availability and good safety profile. Fosfomycin trometamol is approved and widely used in the management of acute cystitis. Other formulations are used intravenously for systemic infections.</p><h4>Pharmacokinetics</h4><p>Single dose pharmacokinetics in healthy adult volunteers following oral fosfomycin trometamol administration.</p><h4>References</h4><ol><li><p>Jariyapamornkoon, N, et al., &amp; Suanpairintr, N (2023). Plasma and Urine Pharmacokinetics of Oral Fosfomycin Tromethamine in Dogs. <i>Veterinary sciences</i> 10(6) –. DOI:<a href=&quot;https://doi.org/10.3390/vetsci10060391&quot;>10.3390/vetsci10060391</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37368777/&quot;>https://pubmed.ncbi.nlm.nih.gov/37368777</a></p></li><li><p>Kane, Z, et al., &amp; Standing, JF (2021). IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis. <i>The Journal of antimicrobial chemotherapy</i> 76(7) 1855–1864. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkab083&quot;>10.1093/jac/dkab083</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33855449/&quot;>https://pubmed.ncbi.nlm.nih.gov/33855449</a></p></li><li><p>Isla, A, et al., &amp; Rodríguez-Gascón, A (2024). Population pharmacokinetics of oral fosfomycin calcium in healthy women. <i>The Journal of antimicrobial chemotherapy</i> 79(11) 2837–2845. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkae295&quot;>10.1093/jac/dkae295</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39205651/&quot;>https://pubmed.ncbi.nlm.nih.gov/39205651</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S02AA17;
